Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetyl-L-carnitine for prevention of sagopilone-induced peripheral neuropathy
ISRCTN75009754Phase 2Completed
- Sponsor
- Bayer
- Start
- Aug 2008
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in ovarian cancer, primary peritoneal cancer (PPC), fallopian tube cancer (PFTC) and 1 more comparing Sagopilone + acetyl-L-carnitine with Sagopilone + placebo (2 arms). Primary endpoint: Overall incidence of peripheral neuropathy. Started Aug 2008; status: completed.
02
Drugs
acetyl-l-carnitinesagopilone
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)fallopian tube cancer (PFTC)castration-resistant prostate cancer (CRPC)
Beyond the preview
Go deeper on ISRCTN75009754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN75009754.